Home600276 • SHA
Jiangsu Hengrui Pharmaceuticals Co Ltd
add
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 7.80B | 34.26% |
Operating expense | 5.18B | 19.06% |
Net income | 1.72B | 107.20% |
Net profit margin | 22.03 | 54.38% |
Earnings per share | — | — |
EBITDA | 1.75B | 143.62% |
Effective tax rate | 17.39% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 25.09B | 20.36% |
Total assets | 50.14B | 14.51% |
Total liabilities | 4.05B | 47.03% |
Total equity | 46.09B | — |
Shares outstanding | 6.36B | — |
Price to book | 6.77 | — |
Return on assets | 7.96% | — |
Return on capital | 8.65% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 1.72B | 107.20% |
Cash from operations | 2.84B | -14.92% |
Cash from investing | -38.54M | -152.36% |
Cash from financing | -44.07M | 19.12% |
Net change in cash | 2.78B | -14.57% |
Free cash flow | 2.74B | -29.26% |
Previous close
¥48.50
Day range
¥47.80 - ¥48.68
Year range
¥37.24 - ¥57.53
Market cap
308.62B CNY
Avg Volume
53.41M
P/E ratio
48.38
Dividend yield
-
Primary exchange
SHA
About
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China. Wikipedia
Founded
Apr 28, 1997
Website
Employees
20,238
